Among them, CCR2-CCL2, CXCR4-CXCL12, and CCR6-CCL20, three pairs of chemokines and their receptors, contribute to forming the inhibitory immune microenvironment and have an obvious effect on promoting tumor progression. This evidence concerns the gene CXCL12 and neoplasm.